Biomarkers and Drug Development: Regulatory Perspective
Christopher Leptak, MD, PhD, Director, DCER Biomarker Qualification Program, U.S. Food & Drug Administration
Towards an International Image Quality Monitoring Framework for Quantitative Imaging: Plan for Global Sharing and Progress
Ricardo S. Avila, MS, Accumetra, LLC
Use of Phantoms and Image Datasets for Regulatory Decision Making
Nicholas Petrick. Ph.D., U.S. Food and Drug Administration (FDA)
VA Partnership to Increase Access to Lung Screening
Claudia Henschke, PhD, MD, Icahn School of Medicine at Mount Sinai
Equity Issues with Lung Cancer Screening
Mary Pasquinelli, MS, APRN, FNP-BC, UI Health
Lung Cancer, COPD and Cardiovascular Disease – Quality is a Gateway to Deep Learning
James L. Mulshine, MD, Rush University
COPD and Early Interception of Lung Cancer
George Washko, MD, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital
Early Assessment of Interstitial Lung Disease: Opportunities in Lung Cancer Screening
Mary Salvatore MD, MBA, Columbia University Medical Center
CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite
Andrea McKee, MD, Lahey Hospital and Medical Center
Imaging Advances in Smoking-related Injury: From COPD to Interstitial Lung Disease
Raúl San José Estépar, PhD, Applied Chest Imaging Laboratory, Brigham and Women’s Hospital
Project ECHO® (Extension for Community Health Outcomes)
Sanjeev Arora, MD, FACG, MACP, University of New Mexico – Project ECHO
